BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 20558207)

  • 1. Evaluation of HIV-1 integrase inhibitors on human primary macrophages using a luciferase-based single-cycle phenotypic assay.
    Michelini Z; Galluzzo CM; Negri DR; Leone P; Amici R; Bona R; Summa V; Di Santo R; Costi R; Pommier Y; Marchand C; Palmisano L; Vella S; Cara A
    J Virol Methods; 2010 Sep; 168(1-2):272-6. PubMed ID: 20558207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a human immunodeficiency virus vector-based, single-cycle assay for evaluation of anti-integrase compounds.
    Bona R; Andreotti M; Buffa V; Leone P; Galluzzo CM; Amici R; Palmisano L; Mancini MG; Michelini Z; Di Santo R; Costi R; Roux A; Pommier Y; Marchand C; Vella S; Cara A
    Antimicrob Agents Chemother; 2006 Oct; 50(10):3407-17. PubMed ID: 17005823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Universal modular system for in vitro screening of potential inhibitors of HIV-1 replication].
    Prokof'eva MM; Orlova NN; Gornostaeva AS; Shul'gin AA; Nikitenko NA; Senchenko VN; Lebedev TD; Spirin PV; Riechen K; Fehse B; Stocking C; Prasolov VS
    Mol Biol (Mosk); 2014; 48(2):344-8. PubMed ID: 25850304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization and structural analysis of HIV-1 integrase conservation.
    Ceccherini-Silberstein F; Malet I; D'Arrigo R; Antinori A; Marcelin AG; Perno CF
    AIDS Rev; 2009; 11(1):17-29. PubMed ID: 19290031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel high-throughput cellular screening assay for the discovery of HIV-1 integrase inhibitors.
    Van Loock M; Meersseman G; Van Acker K; Van Den Eynde C; Jochmans D; Van Schoubroeck B; Dams G; Heyndrickx L; Clayton RF
    J Virol Methods; 2012 Feb; 179(2):396-401. PubMed ID: 22172974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chicoric acid analogues as HIV-1 integrase inhibitors.
    Lin Z; Neamati N; Zhao H; Kiryu Y; Turpin JA; Aberham C; Strebel K; Kohn K; Witvrouw M; Pannecouque C; Debyser Z; De Clercq E; Rice WG; Pommier Y; Burke TR
    J Med Chem; 1999 Apr; 42(8):1401-14. PubMed ID: 10212126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reporter gene expression from LTR-circles as tool to identify HIV-1 integrase inhibitors.
    Van Loock M; Hombrouck A; Jacobs T; Winters B; Meersseman G; Van Acker K; Clayton RF; Malcolm BA
    J Virol Methods; 2013 Feb; 187(2):238-47. PubMed ID: 23178583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selection of diverse and clinically relevant integrase inhibitor-resistant human immunodeficiency virus type 1 mutants.
    Kobayashi M; Nakahara K; Seki T; Miki S; Kawauchi S; Suyama A; Wakasa-Morimoto C; Kodama M; Endoh T; Oosugi E; Matsushita Y; Murai H; Fujishita T; Yoshinaga T; Garvey E; Foster S; Underwood M; Johns B; Sato A; Fujiwara T
    Antiviral Res; 2008 Nov; 80(2):213-22. PubMed ID: 18625269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary mutations selected in vitro with raltegravir confer large fold changes in susceptibility to first-generation integrase inhibitors, but minor fold changes to inhibitors with second-generation resistance profiles.
    Goethals O; Vos A; Van Ginderen M; Geluykens P; Smits V; Schols D; Hertogs K; Clayton R
    Virology; 2010 Jul; 402(2):338-46. PubMed ID: 20421122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and biological evaluation of purine derivatives incorporating metal chelating ligands as HIV integrase inhibitors.
    Li X; Vince R
    Bioorg Med Chem; 2006 Aug; 14(16):5742-55. PubMed ID: 16753300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Symmetrical 1-pyrrolidineacetamide showing anti-HIV activity through a new binding site on HIV-1 integrase.
    Du L; Zhao YX; Yang LM; Zheng YT; Tang Y; Shen X; Jiang HL
    Acta Pharmacol Sin; 2008 Oct; 29(10):1261-7. PubMed ID: 18817633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Styrylquinoline derivatives: a new class of potent HIV-1 integrase inhibitors that block HIV-1 replication in CEM cells.
    Mekouar K; Mouscadet JF; Desmaële D; Subra F; Leh H; Savouré D; Auclair C; d'Angelo J
    J Med Chem; 1998 Jul; 41(15):2846-57. PubMed ID: 9667973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV type 1 integrase inhibitors: from basic research to clinical implications.
    Jegede O; Babu J; Di Santo R; McColl DJ; Weber J; Quiñones-Mateu M
    AIDS Rev; 2008; 10(3):172-89. PubMed ID: 18820719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Azaindole hydroxamic acids are potent HIV-1 integrase inhibitors.
    Plewe MB; Butler SL; Dress KR; Hu Q; Johnson TW; Kuehler JE; Kuki A; Lam H; Liu W; Nowlin D; Peng Q; Rahavendran SV; Tanis SP; Tran KT; Wang H; Yang A; Zhang J
    J Med Chem; 2009 Nov; 52(22):7211-9. PubMed ID: 19873974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of 5-(1-H or 1-alkyl-5-oxopyrrolidin-3-yl)-8-hydroxy-[1,6]-naphthyridine-7-carboxamide inhibitors of HIV-1 integrase.
    Melamed JY; Egbertson MS; Varga S; Vacca JP; Moyer G; Gabryelski L; Felock PJ; Stillmock KA; Witmer MV; Schleif W; Hazuda DJ; Leonard Y; Jin L; Ellis JD; Young SD
    Bioorg Med Chem Lett; 2008 Oct; 18(19):5307-10. PubMed ID: 18774711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-1 integrase inhibitors: 2005-2006 update.
    Dayam R; Gundla R; Al-Mawsawi LQ; Neamati N
    Med Res Rev; 2008 Jan; 28(1):118-54. PubMed ID: 17979144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of a new in vitro reaction substrate reproducing both U3 and U5 regions of the HIV-1 3'-ends increases the correlation between the in vitro and in vivo effects of the HIV-1 integrase inhibitors.
    Tramontano E; Onidi L; Esposito F; Badas R; La Colla P
    Biochem Pharmacol; 2004 May; 67(9):1751-61. PubMed ID: 15081874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [HIV-1 integrase enzyme linked immunosorbent assay and inhibitors].
    Guo Z; Chen H
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2002 Jun; 16(2):119-23. PubMed ID: 12196820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dissecting Tn5 transposition using HIV-1 integrase diketoacid inhibitors.
    Czyz A; Stillmock KA; Hazuda DJ; Reznikoff WS
    Biochemistry; 2007 Sep; 46(38):10776-89. PubMed ID: 17725323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human immunodeficiency virus type 1 (HIV-1) integrase: resistance to diketo acid integrase inhibitors impairs HIV-1 replication and integration and confers cross-resistance to L-chicoric acid.
    Lee DJ; Robinson WE
    J Virol; 2004 Jun; 78(11):5835-47. PubMed ID: 15140981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.